Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients.

Yosuke OsawaSachiyo YoshioYoshihiko AokiMasaaki KorenagaMasatoshi ImamuraTakashi OideMiku OkawaraHironari KawaiYuriko TsutsuiYuichi YoshidaShiori YoshikawaTaizo MoriTaiji YamazoeTatsuya Kanto

Published in: BMC gastroenterology (2021)

ANGP-2 may serve as a useful biomarker for liver angiogenesis and fibrosis in CHC patients. In addition, angiogenesis and fibrosis may be closely related.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
endothelial cells
chronic kidney disease
peritoneal dialysis
prognostic factors
vascular endothelial growth factor
patient reported outcomes